title: What do we know about intraocular carboplatin?
authors.affiliation: 1 Department of Medicine, Memorial Sloan-Kettering Cancer Center , New York, New York.
authors.forename: Kai B
authors.initials: KB
authors.lastname: Kang
authors.forename: Jasmine H
authors.initials: JH
authors.lastname: Francis
authors.forename: David H
authors.initials: DH
authors.lastname: Abramson
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D056965:Injections, Intraocular; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin